Advertisement
To access the live call, dial 877-440-5803 (domestic) or 719-325-4900(international). The live webcast will be available in the Investors sectionof the Company's website, http://www.ilgenetics.com.
Advertisement
Replay access of the teleconference will be available for two weeksfollowing the call by dialing 719-457-0820 (domestic) or 888-203-1112(international). The passcode for the replay is 3385694. The webcast will bearchived following the call at http://www.ilgenetics.com.
About Interleukin Genetics
Interleukin Genetics, Inc. (Amex: ILI) is a genetics-focused personalizedhealth company that develops preventive consumer products and genetic testsfor sale to the emerging personalized health market. Focused on the future ofhealth and medicine, Interleukin uses its leading genetics research andscientific capabilities to develop and test innovative preventive andtherapeutic products. Interleukin Genetics has developed and commercializedgenetic tests for risk assessment of coronary artery disease, periodontaldisease, and general nutrition. The Company currently offers an array ofNutraceuticals and OTCeuticals(R), including Ginkoba(R), Ginsana(R) andVenastat(R) which are sold at the nation's largest food, drug and massretailers. Interleukin is headquartered in Waltham, MA. For more informationabout Interleukin and its ongoing programs, please visithttp://www.ilgenetics.com.
SOURCE Interleukin Genetics, Inc.
